FMC says the moves are part of a capital allocation plan to return up to $4.5B to shareholders in the next five years.
The company also says it will outline five-year strategic plan at its Investor Day, to include targets for revenue compound annual growth rate of 5%-7%, adjusted EBITDA CAGR of 7%-9% and free cash flow conversion growing to ~70%.
Now read: Livent: Alive And Well? »
Subscribe for full text news in your inbox